Q&A: Cancer Commons' Tenenbaum on Building a Patient-Centric System for Personalized Oncology

Jay Tenenbaum, founder of Cancer Commons, believes that the emerging personalized oncology industry needs to approach the discovery-to-market process from a completely new perspective: the patient's.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.